New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend that experts hope will keep downward pressure on U.S. infection ...

Gonorrhoea is a common sexually transmitted infection (STI) that affects millions of people worldwide. Many people who have ...

The FDA has authorized the first at-home testing kits for gonorrhea, chlamydia, and trichomoniasis, along with new gonorrhea ...

Last year, the US authorities approved the first at-home test that can detect three common infections in women — gonorrhea, ...

Food forecasters see a year of quieter tastes: little bursts of pleasure, less-jangling restaurants and healthy foods worthy of the ideal Grandma. Credit...Davide Bonazzi Supported by By Kim Severson ...

Even foods most Americans consider "healthy" can pose serious foodborne illness risks, experts warn — and several say salads, sprouts and deli meats are among the everyday items they personally refuse ...

FARGO, N.D. (Valley News Live) -The U.S. Food and Drug Administration approved two new oral medications in December 2025 to treat uncomplicated urogenital gonorrhea, expanding options as antibiotic ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks. Evaxion will now ...

Nuzolvence oral granules need to be mixed with water and administered within 15 minutes of mixing. The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.